<DOC>
	<DOCNO>NCT02681783</DOCNO>
	<brief_summary>The presence Pigment Epithelial Detachments ( PEDs ) neovascular Age-related Macular Degeneration ( nAMD ) , Central serous chorioretinopathy ( CSR ) idiopathic Poplypoidal Choroidal Vasculopathy ( iPCV ) present diagnostic challenge elderly population ; despite detail diagnostic test differentiate three condition , misdiagnosis mistreatment still occur . One potential way differentiate three condition might compare cytokine profile nAMD versus CSR versus iPCV . This information may useful create diagnostic aqueous cytokine hormone profile differentiate nAMD , CSR iPCV . The primary goal study compare baseline aqueous cytokine cortisol level nAMD , CSR , iPCV patient age-matched cataract control . The secondary objective ass intra-group change visual anatomical outcome nAMD , CSR iPCV patient PED treat aflibercept correlate change baseline cytokine . We compare visual anatomical change group treatment study .</brief_summary>
	<brief_title>PRedictive Factors Changes From Treatment Idiopathic Polypoidal Choroidal Vasuclopathy Versus Central Serous Chorioretinopathy Versus Neovascular Age Related Macular Degeneration With afLibercept</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<criteria>Inclusion criterion study eye group : Greater age 18 Ability provide sign informed consent Capable comply study protocol require diagnostic test Meets study eye criterion respective group ( see ) Exclusion criterion study eye group : Previous intraocular injection include antiVEGF therapy steroid medication , macular laser group Any coexist maculopathy retinopathy study eye Patients history either type I type II diabetes Intraocular surgery study eye within past 4 month Currently systemic steroid therapy form ( drop , skin cream , inhalation/intranasal spray , intravenous ) immunosuppression last 3 month Patients renal dialysis Pregnant nursing mother Patients hypersensitive drug , ingredient formulation , component container . Ocular periocular infection Active intraocular inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>aflibercept</keyword>
</DOC>